Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Negotiations between Altana and Hyal for licensing Solarase terminated

Oct. 19, 1998

Access signs agreement for amlexanox distribution in four additional markets

Oct. 19, 1998

Successful completion of human safety trials reported for VIMRx wound-healing agent

Oct. 14, 1998

Access signs more agreements for distribution of amlexanox

Oct. 14, 1998

More data reported for ADCON-P; FDA okays pivotal trial

Oct. 14, 1998

Demegen's Peptidyl MIM compound D4B effectively treats infected wounds

Oct. 13, 1998

Xoma completes phase II enrollment in psoriasis study

Oct. 13, 1998

Bristol-Myers Squibb and Unilever enter collaborative agreement for hair loss research

Oct. 9, 1998

Nonpeptide BK antagonist effective in guinea pig models of allergy

Oct. 7, 1998

Thalomid now available for prescribing in U.S.

Oct. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...